A new clinical trial demonstrates that hepatocyte growth factor plasmid therapy with AMG0001 is a promising, nonsurgical ...
DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...
NEW HAVEN, Conn., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an ...
Health and Me on MSN
36% Of Rabies Death Comes From India: This Is What You Should Do After A Dog Bite, Explains Doctor
India accounts for over one-third of global rabies deaths, warns WHO. Doctors say rabies can spread through bites or ...
FDA approves FUROSCIX- for use in pediatric patients weighing 43kg or aboveUSPTO issues five patents for FUROSCIX ReadyFlow Autoinjector WESTLAKE VILLAGE, Calif. and BURLINGTON, Mass., Dec. 23, 2025 ...
Dynavax stockholders to receive $15.50 in cash, a 39% premium to Dynavax closing share price onDecember 23, 2025 EMERYVILLE, Calif., Dec. 24, 2025 /PRNewswire/ -- ...
SheBuysTravel on MSN
I spent four nights at a Miami menopause retreat. Here's what I loved, and what I'm still not sure about
I’m a wife, mom and a globetrotting travel writer. I’m also riding the hormonal rollercoaster of perimenopause. Many of the 1 ...
A novel oral antibiotic zoliflodacin is as effective as ceftriaxone plus azithromycin in treating uncomplicated urogenital ...
FP-001 42 mg is an investigational, sustained-release formulation of a GnRH agonist being developed for the treatment of CPP. It is designed to provide continuous suppression of gonadotropin secretion ...
The subcutaneous formulation of the bispecific antibody reduces treatment time to 1 minute vs 2-4 hours with IV infusion.
When the Trump administration slashed foreign aid, it gutted a program that had reduced malaria deaths world wide. In ...
The FDA has granted approval to a subcutaneous formulation of mosunetuzumab (Lunsumio VELO; Genentech/Roche) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback